Verastem, Inc. (VSTM)
5.32
+0.23
(+4.52%)
USD |
NASDAQ |
Mar 26, 12:04
Verastem Cash from Investing (Quarterly) : -1.345M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Altimmune, Inc. | -79.16M |
| ADMA Biologics, Inc. | -0.276M |
| Ocugen, Inc. | -0.035M |
| Zevra Therapeutics, Inc. | 0.227M |
| Immuneering Corp. | -88.72M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.95M |
| Cash from Financing (Quarterly) | 98.58M |
| Free Cash Flow | -147.13M |
| Free Cash Flow Per Share (Quarterly) | -0.3753 |
| Free Cash Flow to Equity (Quarterly) | -28.99M |
| Free Cash Flow to Firm (Quarterly) | -30.88M |
| Free Cash Flow Yield | -38.85% |